Ephb1: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

Target Name: EPHB1

NCBI ID: G2047

EPHB1

Ephb1: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

Ephb1 (HEK6) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Ephb1 plays a crucial role in the regulation of gene expression and has been involved in the development and progression of many diseases. In this article, we will discuss the research on Ephb1 and its potential as a drug target and biomarker.

Structure and Function

Ephb1 is a small non-coding RNA molecule that consists of 194 amino acid residues. It is characterized by a unique open-loop structure that is formed by the fusion of a 12-amino acid loop and a 68-amino acid loop. The 12-amino acid loop is the major structural unit of Ephb1 and is involved in the formation of a distinct N-terminal region. The 68-amino acid loop is the C-terminus of the molecule and is involved in the formation of a distinct C-terminal region.

Ephb1 has been shown to play a role in the regulation of gene expression by binding to specific DNA sequences. This interaction between Ephb1 and DNA has been described as a \"DNA-binding domain\" that consists of multiple domains, including an N-terminal domain, a T-terminal domain, and a variable region. The N-terminal domain is responsible for the formation of the open-loop structure and is involved in the formation of the N-terminal region. The T-terminal domain is involved in the formation of the C-terminal region and is responsible for the formation of the C-terminal region. The variable region is involved in the formation of the unique structure of Ephb1 and is responsible for the binding of Ephb1 to specific DNA sequences.

Ephb1 has been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and transcriptional regulation. Ephb1 has been shown to play a negative role in the regulation of cell growth by inhibiting the formation of new blood vessels in tumors. Ephb1 has also been shown to play a role in the regulation of apoptosis by activating programmed cell death (PCD) in response to DNA damage. Ephb1 has also been shown to play a role in the regulation of transcriptional regulation by binding to specific DNA sequences and regulating the translation of RNA molecules.

Drug Targeting

Ephb1 has been shown to be a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Ephb1 has been shown to play a role in the regulation of cancer cell growth and has been shown to be involved in the development and progression of many types of cancer. For example, studies have shown that Ephb1 is involved in the regulation of the growth and survival of breast cancer cells and that inhibition of Ephb1 activity has the potential to be a useful therapeutic approach for breast cancer treatment.

Ephb1 has also been shown to play a role in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Ephb1 has been shown to play a role in the regulation of the development and progression of neurodegenerative diseases by regulating the expression of genes involved in neurodegeneration. For example, studies have shown that Ephb1 is involved in the regulation of the expression of genes involved in the development and progression of Alzheimer's disease and that inhibition of Ephb1 activity has the potential to be a useful therapeutic approach for the treatment of Alzheimer's disease.

Ephb1 has also been shown to play

Protein Name: EPH Receptor B1

Functions: Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Cognate/functional ephrin ligands for this receptor include EFNB1, EFNB2 and EFNB3. During nervous system development, regulates retinal axon guidance redirecting ipsilaterally ventrotemporal retinal ganglion cells axons at the optic chiasm midline. This probably requires repulsive interaction with EFNB2. In the adult nervous system together with EFNB3, regulates chemotaxis, proliferation and polarity of the hippocampus neural progenitors. In addition to its role in axon guidance also plays an important redundant role with other ephrin-B receptors in development and maturation of dendritic spines and synapse formation. May also regulate angiogenesis. More generally, may play a role in targeted cell migration and adhesion. Upon activation by EFNB1 and probably other ephrin-B ligands activates the MAPK/ERK and the JNK signaling cascades to regulate cell migration and adhesion respectively. Involved in the maintenance of the pool of satellite cells (muscle stem cells) by promoting their self-renewal and reducing their activation and differentiation (By similarity)

The "EPHB1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EPHB1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets